Navigation Links
AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site
Date:2/24/2008

pears to be telling us that we must operate Linn House for services that the majority of people thankfully no longer need. It seems LAHD would prefer that no services be provided, rather than the valuable, lifesaving services which are provided there today, but which are not listed according to their reading of a fourteen year-old contract."

"Following the arrival and widespread availability of lifesaving antiretroviral AIDS drug therapies in 1996, AIDS is no longer a death sentence, and the need for end-of-life hospice care for AIDS patients in Los Angeles and elsewhere in the US quickly diminished, rendering the need for hospice facilities such as Linn House moot," said Donna Stidham, Chief of Managed Care for AIDS Healthcare Foundation. "As a result, AHF ceased operating Linn House as an AIDS hospice in 1999, and we began using the facility to provide services to people with HIV/AIDS, including providing case management, care and treatment for people with HIV/AIDS in the community, as the hub of our Medi-Cal managed care program, Positive Healthcare. The parameters of AIDS care and treatment have changed radically for the better in the last decade: We now work together with patients to help them manage their disease, keep them alive and well and from hopefully ever needing AIDS hospice services. By insisting that the House be used for services that are no longer needed, LAHD is jeopardizing the quality care the people with HIV/AIDS need now."

The disputed contract covers a $1.1 million, forty-year loan granted to AHF by the LAHD in 1994 to help with the construction AHF's Linn House, a 25- bed AIDS hospice located in Los Angeles (near the West Hollywood border) that was initially intended to serve terminally ill AIDS patients during their final days. In order to settle this dispute, AHF made several good faith offers, including one to fully repay the $1.1 million loan provided that the City and Housing Department waive more than $700,000 in interest
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Upscale Yet Affordable Housing Sets New Standard for Seniors
2. Fox Hill Senior Condominium Development Thrives During National Housing Slump
3. Senior Move Managers Announce Online Resource to Simplify Search for Senior Housing
4. Holiday Visits Nudge Many Towards Senior Housing Decision
5. Unstable housing status increases the risk of HIV transmission
6. Ventas Appoints Brush SVP - Senior Housing Development and Operations
7. Emergency Alert - Help for Shelters Housing Animals Evacuated in California Wildfires
8. National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing
9. Adverse housing conditions contribute to diabetes risk
10. Suicide Prevention Agency Announces the Release of a New School-Based Program
11. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. ... men and barbershops are scrambling to meet it. , Reports published this year (Mintel ... and haircare. But the data also reflects that men are getting more done at ...
(Date:8/31/2015)... ... 2015 , ... A year ago this month, Seniors Guide first hit stands ... issue commemorating the successful first year. , “We started the magazine with the ... in their lives,” says Melissa Wolfert, founding Publisher for Seniors Guide Columbus. “Making the ...
(Date:8/31/2015)... ... 2015 , ... Chicago-based company The Mood Factory, with brand ... and awareness for breast and ovarian health. During September and October, The ... to Bright Pink® to encourage households, dorms, and offices around the U.S. to ...
(Date:8/31/2015)... ... ... It’s a lot like coming home. Life-long Fox Valley resident James Holbrook has been ... the job, he’s run into residents of the retirement community who he’s known since ... in such a wonderful place,” he said. GreenFields, which is sponsored by Friendship Senior ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... networking and relationship-marketing firm, announced today the nominees vying for the 2015 ... U.S. Region. Executives include top-ranking decision makers representing national to global organizations ...
Breaking Medicine News(10 mins):Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 2Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 3Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 4
... New research has found that hormone therapy used to treat ... chance of developing various heart problems. Some choices of therapy ... Researchers told Europe,s biggest cancer congress, ECCO 15 ESMO ... findings of their study, the largest and most comprehensive to ...
... , MAHWAH, N.J., Sept. 22 Radware ... application delivery solutions for business-smart networking, today announced ... and South Carolina, has leveraged Radware,s suite of application delivery solutions ... load balancing capabilities for its extensive hospital system. ...
... , , RANDOLPH, Mass., Sept. 22 ... to serving individuals with Autism Spectrum Disorders (ASD), today released its ... and adolescents with ASD ever published. , , ... information about the myriad treatments available for ASD," said Susan M. ...
... Germany, September 22 The,Gerresheimer Group expands its ... significant investments in the USA and,Europe. This week ... research,and development center for medical plastic systems in ... for pharmaceutical plastic packaging in Spain.,"Plastics are increasingly ...
... Corrie Yackulic, ... after nearly twenty years to open her own personal injury law practice. , ... Seattle, Wash. (Lexis Nexis) September 22, 2009 ... at personal injury law firm Schroeter Goldmark & Bender to launch her own personal injury ...
... ... Pelvic Organ Prolapse --provides helpful information about the common conditions of urinary incontinence and ... symptoms, as well as the symptoms of pelvic organ prolapse. Finally, treatment options are ... ...
Cached Medicine News:Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 2Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 3Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 4Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 2Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 3Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 4Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 5Health News:National Autism Center Releases Groundbreaking Report on Autism Treatments 2Health News:National Autism Center Releases Groundbreaking Report on Autism Treatments 3Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 2Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 3Health News:Seattle Personal Injury Attorney Corrie Yackulic Opens Law Firm, Unveils New Website 2Health News:Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments 2Health News:Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments 3
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... 31, 2015  Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today it has completed enrollment of the additional ... (DRC) earlier this year, into the company,s Phase ... innate defense regulator (IDR) and is being evaluated ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... experienced,clinical benefit when treated with daily RAD001 and monthly Sandostatin LAR ... Depot, - 77% of patients with pancreatic NET experienced clinical ... treated with daily RAD001, - Data show RAD001, an oral mTOR ... ...
... Inc.,(Nasdaq: BNVI ) today announced the publishing ... Society for Pharmacology and Experimental Therapeutics, Drug,Metabolism and ... Bioactive Compound Isolated from the Chinese Herbal,Selective Estrogen ... the active compounds of MF101, Bionovo,s drug,candidate for ...
Cached Medicine Technology:RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 2RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 3RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 4RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 5RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 6RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 7Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3
... sensitivity chart test face is the most widely ... test provides for four (4) rows of sine-wave ... ft (2.5 meters), these gratings test the spatial ... The CSV-1000E provides a full contrast sensitivity curve, ...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
Medicine Products: